Image may be NSFW.
Clik here to view.
Executives backed by a Chinese life sciences company have taken control of Cesca Therapeutics Inc., the Rancho Cordova medical equipment and regenerative health company.
In January, the Chinese group of stem-cell research companies called Boyalife Group invested $15 million in Cesca (Nasdaq: KOOL), which was running out of cash to operate.
In August, Boyalife saw debt it held from Cesca converted into stock, which raised Boyalife’s ownership stake in Cesca from 25 percent to 70 percent.
Based…
Clik here to view.
